FindTrial
Sign In

Preoperative axillary lymph node stage using lymphatic contrast enhanced ultrasound guided fine needle aspiration biopsy in breast cancer patients

Preoperative axillary lymph node stage using lymphatic contrast enhanced ultrasound guided fine needle aspiration biopsy in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036495
Enrollment
Unknown
Registered
2020-08-23
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Low proficiency, medium proficiency, high proficiency: preoperative axillary lymph node stage

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were suspected with breast cancer, and categorized as BI-RADS 4c, 5, or 6 by ultrasound, mammography, and/or MRI, and would be scheduled for primary surgical treatment in our hospital.

Exclusion criteria

Exclusion criteria: Patients whose axillary lymph node(s) have been histologically and cytologically proven to be involved, patients who underwent previous ipsilateral breast and/or axillary surgery or radiotherapy, or patients with contraindications for ultrasound contrast use, patients whose lymphatic channels were not displayed in the lymphatic contrast enhanced ultrasound, patients who did not receive an axillary operation for benign or low potential malignant breast mass validation.

Design outcomes

Primary

MeasureTime frame
Preoperative axillary lymph node stage using lymphatic contrast enhanced ultrasound guided fine needle aspiration biopsy;—

Countries

China

Contacts

Public ContactLifang Jin

Shanghai General Hospital

lifang_jin@163.com+86 18918639515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026